Report : Asia Pacific DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], and End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others)

At 9.1% CAGR, the Asia Pacific DNA Extraction, Isolation, and Purification Market is Speculated to be Worth US$ 1,014.29 Million by 2030, Says Business Market Insights

According to Business Market Insights research, the Asia Pacific DNA extraction, isolation, and purification market was valued at US$ 505.36 million in 2022 and is expected to reach US$ 1,014.29 million by 2030, registering a CAGR of 9.1% from 2022 to 2030. Rising R&D in genomics and emerging applications of extracted and purified DNA are among the critical factors attributed to the Asia Pacific DNA extraction, isolation, and purification market expansion.

Genomics holds significant potential for improved diagnostics and treatment of genetic diseases. Genomic DNA extraction is one of the most common procedures in the life sciences. Genomic DNA contains all of an organism\'s genetic and chromosomal material and encodes all of the components required for life. The emergence of cutting-edge technologies for sequencing, and assembly and analysis of sequenced data is likely to strengthen the importance of genomics in medicine and other branches of science. Thus, government and nongovernment agencies are taking initiatives to boost genomic research. The funding enables researchers to provide world-class genomic healthcare, which involves the study of people\'s DNA as a core job.

On the contrary, high cost of process and need for highly skilled workforces hampers the growth Asia Pacific DNA extraction, isolation, and purification market.

Based on type, the Asia Pacific DNA extraction, isolation, and purification market is categorized into Kits, instrument, and reagent. The kits segment held 63.0% share of the Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 318.59 million. It is projected to garner US$ 654.63 million by 2030 to expand at 9.4% CAGR during 2022-2030.

In terms of method, the Asia Pacific DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held 83.0% share of the Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 419.28 million. It is projected to garner US$ 842.81 million by 2030 to expand at 9.1% CAGR during 2022-2030. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the Asia Pacific DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held 53.0% share of Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 267.71 million. It is projected to garner US$ 542.43 million by 2030 to expand at 9.2% CAGR during 2022-2030.

By source, the Asia Pacific DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held 78.3% share of Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 395.87 million. It is projected to garner US$ 799.61 million by 2030 to expand at 9.2% CAGR during 2022-2030.The microbial segment is further subsegmented into bacteria and virus.

Based on application, the Asia Pacific DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held 40.9% share of the Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 206.47 million. It is projected to garner US$ 419.64 million by 2030 to expand at 9.3% CAGR during 2022-2030. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end user, the Asia Pacific DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held 48.6% share of Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 245.77 million. It is projected to garner US$ 494.83 million by 2030 to expand at 9.1% CAGR during 2022-2030.

Based on country, the Asia Pacific DNA extraction, isolation, and purification market is categorized into China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and the Rest of Asia Pacific. China held 32.6% share of Asia Pacific DNA extraction, isolation, and purification market in 2022, amassing US$ 164.96 million. It is projected to garner US$ 348.59 million by 2030 to expand at 9.8% CAGR during 2022-2030.

Key players operating in the Asia Pacific DNA extraction, isolation, and purification market are Agilent Technologies, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc, Illumina Inc, Merck KGaA, Qiagen NV, Takara Bio Inc, and Thermo Fisher Scientific Inc among others.

- In Aug 2023, Thermo Fisher Scientific launched a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for a wide range of prenatal, postnatal and oncology research applications, the Applied Biosystems CytoScan HD Accel array analyzes the whole human genome and provides improved coverage in more than 5,000 critical genome regions.

- In Jul 2023, QIAGEN launched of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com

Download Free PDF Brochure